期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Potential of transposon-mediated cellular reprogramming towards cell-based therapies 被引量:1
1
作者 Dharmendra Kumar Taruna Anand +1 位作者 Thirumala R Talluri Wilfried A Kues 《World Journal of Stem Cells》 SCIE CAS 2020年第7期527-544,共18页
Induced pluripotent stem(iPS)cells present a seminal discovery in cell biology and promise to support innovative treatments of so far incurable diseases.To translate iPS technology into clinical trials,the safety and ... Induced pluripotent stem(iPS)cells present a seminal discovery in cell biology and promise to support innovative treatments of so far incurable diseases.To translate iPS technology into clinical trials,the safety and stability of these reprogrammed cells needs to be shown.In recent years,different non-viral transposon systems have been developed for the induction of cellular pluripotency,and for the directed differentiation into desired cell types.In this review,we summarize the current state of the art of different transposon systems in iPS-based cell therapies. 展开更多
关键词 TRANSPOSONS Induced pluripotent stem cells Clinical applications Cellular reprogramming Cell-based therapy Genetic correction
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部